US Food and Drug Administration Extends Phexxi® Shelf Life to Four Years

SAN DIEGO, June 2, 2022 /PRNewswire/ — Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced that the U.S. Food and Drug Administration (FDA) has formally extended the shelf life of Phexxi® (lactic acid, citric acid, potassium bitartrate) from three to four years. “The FDA’s…

Click here to view original post